With over €3.6 billion in investments managed by its team of nearly 95 professionals, Andera Partners focuses on supporting companies and their managers in achieving strong and sustainable growth. They have a particular interest in medical therapy, cross-border companies, and small to mid-cap French companies. Andera Partners has a track record of successful investments and has exited from companies such as Axonics Modulation Technologies and Vivoryon Therapeutics. They are based in Paris and are committed to environmental sustainability, having been certified carbon neutral since 2018.